Social Security's trust fund faces earlier depletion in 2034, potentially cutting benefits by 23% for 70 million Americans unless Congress acts. Trump Cancels Trail, Bike-Lane Grants Deemed ‘Hostile’ ...
Alzheimer’s disease is the most common form of dementia, affecting 57 million people worldwide, with 10 million new cases reported each year. This terrible affliction is like a thief, stealing the ...
Former President Joe Biden has gone under the knife to remove skin cancer lesions just a few months after revealing his prostate cancer diagnosis. Biden, 82, sparked concern after he was seen with a ...
New research based on 22 years of satellite data shows vast areas of the world are losing fresh water and getting drier. These regions include much of the American West, Mexico, Central America and ...
SANTA FE — Gov. Michelle Lujan Grisham recently underwent a medical procedure on her shoulder that might keep her off the pickleball court for the near future, but not home from work. After Lujan ...
Phosphorus is integral to agriculture and human life. We can’t grow any of our food without it. Of the phosphorus fertilizers applied, perhaps 20% ends up consumed in the final product. Large amounts ...
The trustees for Social Security and Medicare released their annual report on the status of the entitlement programs' trust funds, which are expected to be depleted sooner than previously thought. The ...
ABSTRACT: Subcutaneous white adipose tissue (sWAT) can be described micromechanically as a foam structure. It is shown that according to this model, mechanical stiffness of this tissue is primarily ...
Last week, the American College of Obstetricians and Gynecologists (ACOG) acknowledged in writing what people with a uterus have shouted from the rooftops for years: In-office gynecological procedures ...
The increasing frequency of once-in-a-decade agricultural and ecological drought has underscored the urgency of studying hydrological changes. A research team has analyzed the estimated changes in ...
Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely focused on CAR-Ts and bispecifics, the German drugmaker has paid Cue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback